IL18 and diabetes mellitus: Under “diabetes-like” conditions, WT HspB4/αA-crystallin overexpression led to the significant reduction of the induction of IL-6 (55%), IL-1β (36%), IL-18 (93%), and MCP-1 (85%) by MGCs (HspB4−/−) (Figure 3).